A clinical trial has shown that patients with cardiovascular disease who need cardiac rehabilitation were more likely to take part in a digital programme than face-to-face sessions.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
